Risk factors for drug-related non-infectious pneumonia: insights from the FDA adverse event reporting system (FAERS)
These findings could assist clinicians in the early identification of drug-related NIP and provide valuable insights for future research into the mechanisms underlying drug-related NIP.
Authors
- Zheng Ruan (ORCID: https://orcid.org/0000-0001-9638-1466)
- Qingnan Zhao (ORCID: https://orcid.org/0000-0001-9389-8566)
- Yi Zhang (ORCID: https://orcid.org/0000-0001-9861-4681)
- Hang Zhang (ORCID: https://orcid.org/0000-0002-8319-2858)
- Peize Meng (ORCID: https://orcid.org/0000-0002-1913-8945)
Institutions
- Shanghai Jiao Tong University (CN)
Publication Details
- Journal
- Expert Opinion on Drug Safety
- Published
- 2025-05-05
- DOI
- https://doi.org/10.1080/14740338.2025.2500716
- Primary Topic
- Pharmacovigilance and Adverse Drug Reactions
- Type
- article
- Field-Weighted Citation Impact
- 0.00